Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2000
Successful reversal of recalcitrant hepatic allograft rejection by photopheresisM S Lehrer, E Ruchelli, K M Olthoff, et al.
Current Opinion in Oncology|June 18, 2009
Update on treatment of cutaneous T-cell lymphomaJennifer M Gardner, Katherine G Evans, Amy Musiek, et al.
Current Oncology Reports|August 12, 2006
Mycosis fungoides and sezary syndrome: an updateEllen J Kim, Julie Lin, Jacqueline M Junkins-Hopkins, et al.
Archives of Dermatology|June 18, 2003
Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphomaKaren S McGinnis, Michael Shapiro, Carmela C Vittorio, et al.
Ciba Foundation Symposium|January 1, 1989
Extracorporeal photochemotherapy in the treatment of cutaneous T cell lymphoma and autoimmune disorders affecting the skinA H Rook, G T Nahass, B J Macelis, et al.
Journal of the American Academy of Dermatology|November 17, 2001
Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapyL E French, M Shapiro, J M Junkins-Hopkins, et al.
Journal of the American Academy of Dermatology|November 26, 2003
Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfaLars E French, Michael Shapiro, Jacqueline M Junkins-Hopkins, et al.
Blood|August 26, 2004
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15Maria Wysocka, Bernice M Benoit, Sarah Newton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cellsA H Rook, H C Lane, T Folks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
IL-12 synthesis by human Langerhans cellsK Kang, M Kubin, K D Cooper, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2000
Successful reversal of recalcitrant hepatic allograft rejection by photopheresisM S Lehrer, E Ruchelli, K M Olthoff, et al.
Current Opinion in Oncology|June 18, 2009
Update on treatment of cutaneous T-cell lymphomaJennifer M Gardner, Katherine G Evans, Amy Musiek, et al.
Current Oncology Reports|August 12, 2006
Mycosis fungoides and sezary syndrome: an updateEllen J Kim, Julie Lin, Jacqueline M Junkins-Hopkins, et al.
Archives of Dermatology|June 18, 2003
Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphomaKaren S McGinnis, Michael Shapiro, Carmela C Vittorio, et al.
Ciba Foundation Symposium|January 1, 1989
Extracorporeal photochemotherapy in the treatment of cutaneous T cell lymphoma and autoimmune disorders affecting the skinA H Rook, G T Nahass, B J Macelis, et al.
Journal of the American Academy of Dermatology|November 17, 2001
Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapyL E French, M Shapiro, J M Junkins-Hopkins, et al.
Journal of the American Academy of Dermatology|November 26, 2003
Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfaLars E French, Michael Shapiro, Jacqueline M Junkins-Hopkins, et al.
Blood|August 26, 2004
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15Maria Wysocka, Bernice M Benoit, Sarah Newton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cellsA H Rook, H C Lane, T Folks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
IL-12 synthesis by human Langerhans cellsK Kang, M Kubin, K D Cooper, et al.
Pageof 19